Claes Thulin leaving BioPhausia
(Thomson Reuters ONE) - BioPhausia's CEO Claes Thulin is leaving his post in order to pursueentrepreneurial activities. The change of CEO is supported by the Board, whichhas already started the process of recruiting a successor.With Claes Thulin at the helm, BioPhausia evolved from a small research companyinto a successful pharmaceutical company occupying a strong market position. "AsClaes leaves his position, with the full support of the Board, we would takethis opportunity to thank him for his sterling work during his years as CEO,"says BioPhausia's Chairman of the Board Jan Rynning.Mr. Thulin has offered to stay on as CEO until a successor is in place."After eight years as CEO I want to try something different, and intend topursue entrepreneurial activities in the area of pharmaceuticals," he explains.For more information, please contact:Jan Rynning, Chairman of the Board, tel. +46 (0)703510005Claes Thulin, CEO, tel. +46 (0)8 4076430[HUG#1384127] Press Release (PDF): http://hugin.info/130049/R/1384127/342881.pdf
Unternehmensinformation / Kurzprofil:
Datum: 12.02.2010 - 15:19 Uhr
Sprache: Deutsch
News-ID 12457
Anzahl Zeichen: 0
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 177 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Claes Thulin leaving BioPhausia"
steht unter der journalistisch-redaktionellen Verantwortung von
BioPhausia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
